Diclofenac hydroxyethylpyrrolidine

Drug Profile

Diclofenac hydroxyethylpyrrolidine

Alternative Names: Effigel; Flector EP Tissugel; Flector Patch; Flector Tissugel

Latest Information Update: 10 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator IBSA
  • Developer IBSA; Pfizer
  • Class Analgesics; Nonsteroidal anti-inflammatories; Phenylacetates; Small molecules
  • Mechanism of Action Cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Pain

Most Recent Events

  • 01 May 2014 Institut Biochemique SA plans a phase IV trial for Pain (In children with soft tissue injuries) in USA (NCT02132247)
  • 01 Mar 2011 King Pharmaceuticals has been acquired by Pfizer
  • 31 Dec 2008 Alpharma has been acquired by King Pharmaceuticals
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top